SKYE
COM:SKYEBIOSCIENCE
Skye Bioscience
- Stock
Last Close
2.71
12/03 20:00
Market Cap
84.34M
Beta: -
Volume Today
72.99K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 6.51K - | 3.23M - | |||||||||
average payables | 205.82K - | 267.43K 29.93% | 200.00K 25.21% | 187.79K 6.11% | 58.26K 68.98% | 77.70K 33.38% | 260.59K 235.37% | 640.69K 145.86% | 1.35M 110.31% | 1.48M 9.49% | |
average receivables | 12.67K - | 116.18K - | |||||||||
book value per share | -0.04 - | 0.03 163.10% | -0.08 375.39% | -0.03 62.56% | -0.13 348.02% | 0.00 103.16% | 0.00 51.82% | 0.01 638.25% | -0.01 137.56% | -0.30 5,516.89% | |
capex per share | -0.00 - | -0.00 94.82% | -0.00 401.42% | -0.00 20.04% | -0.00 94.86% | -0.00 - | -0.00 613.23% | -0.00 77.39% | 0.00 3,644.77% | ||
capex to depreciation | -12.19 - | -0.20 98.37% | -0.75 274.27% | -2.44 228.03% | -2.84 16.16% | -3.86 - | -2.66 31.07% | -0.24 90.83% | 0.10 141.39% | ||
capex to operating cash flow | 0.01 - | 0.00 95.99% | 0.00 488.53% | 0.01 90.45% | 0.00 81.34% | 0.00 - | 0.01 1,075.12% | 0.00 84.31% | -0.00 140.85% | ||
capex to revenue | |||||||||||
cash per share | 0.02 - | 0.19 844.02% | 0.00 98.20% | 0.01 172.29% | 0.02 64.22% | 0.01 11.49% | 0.01 20.96% | 0.02 106.44% | 0.00 89.86% | 0.18 7,901.54% | |
days of inventory on hand | -2.22K - | ||||||||||
days payables outstanding | 3.40K - | ||||||||||
days sales outstanding | |||||||||||
debt to assets | 0.42 - | 0.70 64.89% | 0.19 72.12% | 0.56 189.20% | 0.22 61.34% | 0.21 2.41% | 0.37 73.11% | ||||
debt to equity | -0.29 - | -0.09 70.23% | 0.71 907.59% | 3.32 370.46% | 0.36 89.04% | -0.64 275.88% | -2.05 220.12% | ||||
dividend yield | |||||||||||
earnings yield | -0.00 - | -0.00 1,091.11% | -0.00 36.03% | -0.00 31.34% | -0.00 45.71% | 0.00 115.05% | -0.00 1,292.12% | -0.00 43.29% | -0.01 437.31% | -1.98 22,703.32% | |
enterprise value | 19.94B - | 2.96B 85.15% | 1.43B 51.69% | 1.06B 25.87% | 12.11B 1,042.48% | 4.41B 63.61% | 2.31B 47.68% | 5.28B 128.87% | 2.25B 57.39% | 22.42M 99.00% | |
enterprise value over ebitda | -7.30K - | -618.32 91.54% | -246.70 60.10% | -282.90 14.67% | -2.51K 786.98% | -663.56 73.56% | -366.86 44.71% | -675.47 84.12% | -186.02 72.46% | -1.65 99.11% | |
ev to operating cash flow | -11.36K - | -794.26 93.01% | -402.61 49.31% | -321.51 20.14% | -3.07K 855.65% | -731.37 76.20% | -380.98 47.91% | -815.30 114.00% | -176.52 78.35% | -1.61 99.09% | |
ev to sales | |||||||||||
free cash flow per share | -0.17 - | -0.22 27.43% | -0.19 14.58% | -0.12 36.79% | -0.03 72.60% | -0.04 36.89% | -0.03 41.10% | -0.02 38.53% | -0.02 42.44% | -1.99 8,565.64% | |
free cash flow yield | -0.00 - | -0.00 1,310.86% | -0.00 97.99% | -0.00 25.58% | -0.00 89.59% | -0.00 319.52% | -0.00 92.18% | -0.00 52.71% | -0.01 357.22% | -0.73 12,802.89% | |
graham net net | -0.06 - | 0.01 118.51% | -0.09 943.57% | -0.04 56.42% | -0.13 228.83% | 0.00 102.18% | 0.00 61.83% | 0.01 1,040.19% | -0.02 259.51% | -1.87 9,429.33% | |
graham number | 0.51 - | 0.42 17.61% | 0.54 27.13% | 0.27 50.25% | 0.68 153.01% | 0.03 96.06% | 0.04 32.67% | 0.08 133.29% | 0.07 20.71% | 6.07 9,174.79% | |
income quality | 0.64 - | 0.77 19.96% | 1.12 45.18% | 1.07 4.66% | 0.21 80.73% | -5.73 2,889.77% | 0.92 116.10% | 0.76 17.67% | 0.65 13.90% | 0.37 43.34% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -8.27 - | 3.45 141.80% | -5.79K 167,584.38% | -49.52 99.14% | -6.71 86.44% | -8.90 32.60% | -10.22 14.85% | -27.53 169.25% | -15.09 45.20% | ||
interest debt per share | 0.03 - | -0.07 321.48% | 0.01 112.36% | 0.01 42.28% | 0.01 15.34% | 0.01 6.10% | 0.01 25.24% | 0.00 34.62% | 0.75 16,038.14% | ||
inventory turnover | -0.16 - | ||||||||||
invested capital | -0.29 - | -0.09 70.23% | 0.71 907.59% | 3.32 370.46% | 0.36 89.04% | -0.64 275.88% | -1.97M 307,333,475.31% | ||||
market cap | 19.94B - | 2.96B 85.13% | 1.43B 51.74% | 1.06B 25.87% | 12.12B 1,042.50% | 4.41B 63.60% | 2.31B 47.68% | 5.29B 129.07% | 2.25B 57.45% | 19.06M 99.15% | |
net current asset value | -493.50K - | 413.73K 183.84% | -1.49M 461.29% | -801.49K 46.38% | -15.57M 1,842.11% | 546.08K 103.51% | 443.44K 18.79% | 5.62M 1,167.61% | -3.18M 156.49% | -2.42M 23.75% | |
net debt to ebitda | 0.08 - | 0.67 785.64% | 0.01 98.34% | 0.01 40.45% | 0.10 1,431.92% | 0.22 112.94% | 0.15 28.84% | 0.88 466.92% | -0.06 106.44% | -0.25 339.25% | |
net income per share | -0.27 - | -0.29 7.58% | -0.17 41.31% | -0.11 33.89% | -0.16 42.88% | 0.01 104.91% | -0.03 465.34% | -0.02 26.28% | -0.04 67.39% | -5.37 15,214.82% | |
operating cash flow per share | -0.17 - | -0.22 29.05% | -0.19 14.80% | -0.12 36.97% | -0.03 72.46% | -0.04 37.04% | -0.03 41.17% | -0.02 39.31% | -0.02 44.12% | -1.99 8,576.92% | |
payables turnover | 0.11 - | ||||||||||
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -7.85 - | -1.38 82.43% | -9.83 612.79% | -5.55 43.50% | -9.81 76.61% | 0.53 105.37% | -2.46 566.16% | -0.86 64.78% | -2.14 147.27% | -3.15 47.45% | |
revenue per share | |||||||||||
roe | 6.03 - | -10.28 270.50% | 2.19 121.31% | 3.87 76.56% | 1.23 68.11% | 1.92 55.60% | -14.55 858.34% | -1.45 90.01% | 6.48 545.65% | 17.66 172.66% | |
roic | 6.03 - | -9.17 252.10% | 3.08 133.62% | 6.83 121.65% | 0.33 95.16% | -7.08 2,243.07% | -3.23 54.42% | -0.96 70.21% | 18.28 2,000.18% | -6.10 133.40% | |
sales general and administrative to revenue | |||||||||||
shareholders equity per share | -0.04 - | 0.03 163.10% | -0.08 375.39% | -0.03 62.56% | -0.13 348.02% | 0.00 103.16% | 0.00 51.82% | 0.01 638.25% | -0.01 137.56% | -0.30 5,516.89% | |
stock based compensation to revenue | |||||||||||
tangible asset value | -453.55K - | 471.00K 203.85% | -1.45M 408.05% | -800.08K 44.86% | -15.56M 1,845.09% | 548.06K 103.52% | 450.79K 17.75% | 5.86M 1,200.88% | -3.01M 151.30% | -2.13M 29.13% | |
tangible book value per share | -0.04 - | 0.03 163.10% | -0.08 375.39% | -0.03 62.56% | -0.13 348.02% | 0.00 103.16% | 0.00 51.82% | 0.01 638.25% | -0.01 137.56% | -0.30 5,516.89% | |
working capital | -492.69K - | 2.87M 682.91% | -382.47K 113.32% | -250.16K 34.59% | -13.99M 5,490.47% | 1.02M 107.32% | 1.88M 83.33% | 5.70M 203.64% | -3.18M 155.71% | -2.25M 29.14% |
All numbers in USD (except ratios and percentages)